期刊
EUROPEAN RESPIRATORY JOURNAL
卷 60, 期 3, 页码 -出版社
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.00984-2022
关键词
-
资金
- Chiesi
- AstraZeneca
- GSK
- BI
- Pfizer
- Teva
- Sanofi
- Novartis
- Iqvia
- Avillion
- ElpenPharmaceuticals
- Exobiologics
Bronchopulmonary dysplasia is a chronic respiratory disease characterized by inflammation, starting in childhood and possibly continuing into adulthood.
Bronchopulmonary dysplasia is a chronic respiratory disease involving inflammation that occurs in childhood and may continue into adult age. BPD can be considered the earliest and longest lasting obstructive lung disease in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据